Coronary angiographic findings in African-American and white patients from a single institutionYOULIAN LIAO; GHALI, Jalal K; BERZINS, Lize et al.Journal of the National Medical Association. 2001, Vol 93, Num 12, pp 465-474, issn 0027-9684Article

Effect of Dronedarone on Exercise Capacity and Cardiac Function in Patients With Severe Left Ventricular Dysfunction and Compensated Stable Heart FailureBARRY LEVINE, T; GILES, Thomas; RADZIK, David et al.Cardiovascular drugs and therapy. 2010, Vol 24, Num 5-6, pp 449-458, issn 0920-3206, 10 p.Article

Conivaptan : A dual receptor vasopressin V_1a/V₂ antagonistALI, Farhan; RAUFI, M. Adnan; WASHINGTON, Barbara et al.Cardiovascular drug reviews (Print). 2007, Vol 25, Num 3, pp 261-279, issn 0897-5957, 19 p.Article

Therapeutic potential of vasopressin receptor antagonistsALI, Farhan; GUGLIN, Maya; VAITKEVICIUS, Peter et al.Drugs (Basel). 2007, Vol 67, Num 6, pp 847-858, issn 0012-6667, 12 p.Article

Gender and Ethnic Differences in Red Cell Distribution Width and Its Association With Mortality Among Low Risk Healthy United State AdultsZALAWADIYA, Sandip K; VEERANNA, Vikas; PANAICH, Sidakpal S et al.The American journal of cardiology. 2012, Vol 109, Num 11, pp 1664-1670, issn 0002-9149, 7 p.Article

Heart Failure Guidelines, Performance Measures, and the Practice of Medicine: Mind the GapGHALI, Jalal K; MASSIE, Barry M; MANN, Douglas L et al.Journal of the American College of Cardiology. 2010, Vol 56, Num 25, pp 2077-2080, issn 0735-1097, 4 p.Article

Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failureSILVER, Marc A; HORTON, Darlene P; GHALI, Jalal K et al.Journal of the American College of Cardiology. 2002, Vol 39, Num 5, pp 798-803, issn 0735-1097Article

Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failureWU, Audrey H; GHALI, Jalal K; NEUBERG, Gerald W et al.The American heart journal. 2010, Vol 160, Num 5, pp 928-933, issn 0002-8703, 6 p.Article

Evidence for the continued safety and tolerability of fixed-dose Isosorbide Dinitrate /Hydralazine in patients with chronic heart failure (the extension to african-american heart failure trial)YANCY, Clyde W; GHALI, Jalal K; BRAMAN, Virginia M et al.The American journal of cardiology. 2007, Vol 100, Num 4, pp 684-689, issn 0002-9149, 6 p.Article

Efficacy, safety and tolerability of β-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failureDEEDWANIA, Prakash C; GOTTLIEB, Stephen; GHALI, Jalal K et al.European heart journal. 2004, Vol 25, Num 15, pp 1300-1309, issn 0195-668X, 10 p.Article

Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: Experiences from MERIT-HFJANOSI, Andras; GHALI, Jalal K; HERLITZ, Johan et al.The American heart journal. 2003, Vol 146, Num 4, pp 721-728, issn 0002-8703, 8 p.Article

Metoprolol CR/XL in female patients with Heart failure: Analysis of the experience in metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF)GHALI, Jalal K; PINA, Ileana L; GOTTLIEB, Stephen S et al.Circulation (New York, N.Y.). 2002, Vol 105, Num 13, pp 1585-1591, issn 0009-7322Article

Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care : Comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trial. CommentaryLAVIE, Carl J; MILANI, Richard V; O'KEEFE, James H et al.Mayo Clinic proceedings. 2007, Vol 82, Num 5, issn 0025-6196, 539-542,543-550 [12 p.]Article

Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure : an analysis from the OPTIMIZE-HF registry. CommentaryGHALI, Jalal K; GHEORGHIADE, Mihai; FONAROW, Gregg C et al.European heart journal. 2007, Vol 28, Num 8, issn 0195-668X, 920-921,980-988 [11 p.]Article

Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: Experiences from MERIT-HFDEEDWANIA, Prakash C; GILES, Thomas D; WIKSTRAND, John et al.The American heart journal. 2005, Vol 149, Num 1, pp 159-167, issn 0002-8703, 9 p.Article

Cardiac Resynchronization Therapy Reduces the Risk of Hospitalizations in Patients With Advanced Heart Failure : Results From the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) TrialANAND, Inder S; CARSON, Peter; LEIGH, Jill et al.Circulation (New York, N.Y.). 2009, Vol 119, Num 7, pp 969-977, issn 0009-7322, 9 p.Article

Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York heart association class IV heart failureLINDENFELD, Joann; FELDMAN, Arthur M; DEMARCO, Teresa et al.Circulation (New York, N.Y.). 2007, Vol 115, Num 2, pp 204-212, issn 0009-7322, 9 p.Article

Acute hemodynamic effects of conivaptan, a dual V_1A and V₂ vasopressin receptor antagonist, in patients with advanced Heart failureUDELSON, James E; SMITH, William B; KONSTAM, Marvin A et al.Circulation (New York, N.Y.). 2001, Vol 104, Num 20, pp 2417-2423, issn 0009-7322Article

Prospective assessment of the occurrence of anemia in patients with heart failure: Results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) RegistryADAMS, Kirkwood F; PATTERSON, John H; FELKER, Gary M et al.The American heart journal. 2009, Vol 157, Num 5, pp 926-932, issn 0002-8703, 7 p.Article

The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction : The VALIANT echo studyVERMA, Anil; ANAVEKAR, Nagesh S; MERIS, Alessandra et al.Journal of the American College of Cardiology. 2007, Vol 50, Num 13, pp 1238-1245, issn 0735-1097, 8 p.Article

A phase 1-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic parameters in patients with chronic heart failure with reduced systolic functionGHALI, Jalal K; SMITH, William B; GHEORGHIADE, Mihai et al.The American journal of cardiology. 2007, Vol 99, Num 2A, issn 0002-9149, 47A-56A, SUPArticle

Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT studyBURGER, Andrew J; HORTON, Darlene P; ELKAYAM, Uri et al.The American heart journal. 2002, Vol 144, Num 6, pp 1102-1108, issn 0002-8703, 7 p.Article

Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or bothSHAH, Amil M; HUNG, Chung-Lieh; PFEFFER, Marc A et al.The American heart journal. 2011, Vol 162, Num 4, pp 685-691, issn 0002-8703, 7 p.Article

Usefulness of Right Ventricular Fractional Area Change to Predict Death, Heart Failure, and Stroke Following Myocardial Infarction (from the VALIANT ECHO Study)ANAVEKAR, Nagesh S; SKALI, Hicham; SOLOMON, Scott D et al.The American journal of cardiology. 2008, Vol 101, Num 5, pp 607-612, issn 0002-9149, 6 p.Article

Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarctionSOLOMON, Scott D; SKALI, Hicham; VELAZQUEZ, Eric J et al.Circulation (New York, N.Y.). 2005, Vol 111, Num 25, pp 3411-3419, issn 0009-7322, 9 p.Article